Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia

NCT02232503 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4011

Last updated 2016-09-22

No results posted yet for this study

Summary

The aim of the study is to find out prevalence and individual stages of Diabetic Retinopathy in patients with type 1 and type 2 DM verified based on complex ophthalmologic measurements in Slovak Republic. The outcome of the project will be epidemiology survey, prevalence of diabetic retinopathy (DR) and diabetic macular edema (DME) in relation to type and duration of diabetes mellitus and risk factors. Project will also identify genetic factors linked with the diseases.

Conditions

Interventions

GENETIC

Studied cohort

For the purpose of DNA isolation prior to genetic analysis of patients two samples of peripheral blood will be taken; first in the volume of 3.5 ml and second in the volume of 9 ml from each patient included into the study.

Sponsors & Collaborators

  • Medirex Group Academy

    collaborator UNKNOWN
  • Slovak Technical University

    collaborator UNKNOWN
  • Comenius University

    collaborator OTHER
  • Novartis Slovakia, s.r.o.

    lead INDUSTRY

Principal Investigators

  • Dagmar Buckova, M.D. · Novartis Slovakia

  • Peter Carnogursky, MSc. · Novartis Slovakia, s.r.o.

  • Svetlana Sefcikova, MD · Novartis Slovakia, s.r.o.

  • Pavol Tison, MD · Novartis Slovakia, s.r.o.

  • Iveta Tvrda, MD · Novartis Slovakia, s.r.o.

  • Daniela Gasperikova, MSc., PhD. · Novartis Slovakia, s.r.o.

  • Ivana Hojsikova, RNDr. · Medirex Group Academy

  • Ludevit Kadasi, RNDr., DrSc. · Comenius University

  • Iwar Klimes, Prof., MD, DrSc. · Novartis Slovakia, s.r.o.

  • Peter Jackuliak, MD · University Hospital Bratislava

  • Vladimir Krasnik, MD PhD. · University Hospital Bratislava

  • Emil Martinka, MD, PhD. · National Institute for Endocrinology and Diabetology

  • Marian Mokan, Prof. MD DrSc. · Jesenius University Martin

  • Zuzana Nemethyova, MD · Diabetology Dispensary Bratislava

  • Marta Ondrejkova, MD PhD. · F.D. Roosevelt Hospital Banska Bystrica

  • Jana Stefanickova, MD · University Hospital Bratislava

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-11-30
Completion
2015-11-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02232503 on ClinicalTrials.gov